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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.001Decorin, a small leucine-rich proteoglycan (SLRP), is involved in the pathophysiology of human
congenital stromal corneal dystrophy (CSCD). This disease is characterized by corneal opacities and
vision impairment. In reported cases, the human gene encoding decorin contains point mutations in
exon 10, generating a truncated form of decorin lacking the C-terminal 33 amino acid residues. We have
previously described a transgenic mouse model carrying a similar mutation in the decorin gene that
leads to an ocular phenotype characterized by corneal opacities identical to CSCD in humans. We have
also identiﬁed abnormal synthesis and secretion of various SLRPs in mutant mouse corneas. In the
present study, we found that mutant C-terminal truncated decorin was retained in the cytoplasm of
mouse keratocytes in vivo and of transfected human embryonic kidney cells. This resulted in endo-
plasmic reticulum stress and an unfolded protein response. Thus, we propose a novel cell-based
mechanism underlying CSCD in which a truncated SLRP protein core is retained intracellularly, its
accumulation triggering endoplasmic reticulum stress that results in abnormal SLRP synthesis and
secretion, which ultimately affects stromal structure and corneal transparency. (Am J Pathol 2013, 183:
247e256; http://dx.doi.org/10.1016/j.ajpath.2013.04.001)Supported by grant NIHEY05129 (D.E.B.).Decorin is a multifunctional small leucineerich proteoglycan
(SLRP) that interacts with collagen ﬁbrils and regulates ﬁbril-
logenesis in extracellular matrix assembly. It also interacts with
a variety of growth factors and receptors and is involved in
pathologic and physiologic processes such as ﬁbrosis, tumor
growth, and cell adhesion.1e5 Human congenital stromal
corneal dystrophy (CSCD) is the only known human disease
associated with a mutated decorin gene. Three different
frameshift mutations have been reported, all leading to iden-
tical truncation of the C-terminal 33 amino acids of decorin.6e8
Decorin is an important regulator of matrix assembly in many
connective tissues such as the cornea, sclera, and tendon.1
However, the only clinical manifestation of autosomal domi-
nant human CSCD is a corneal stromal phenotype,9 which
indicates that truncation interferes with corneal stromal
assembly in a tissue-speciﬁc manner.stigative Pathology.
.A transgenic mouse model (952delTDcn) faithfully reca-
pitulates the phenotype of human CSCD.10 The mouse model
exhibits opaque corneas with a similarly disrupted corneal
stromal structure and abnormal keratocyte architecture, as
observed in the disease in humans.6,10 In addition to the
structural defects in the mouse model, altered expression of
stromal extracellular matrix components, in particular,
expression of SLRPs, is observed. The changes in these SLRPs
are consistent with dysregulated ﬁbrillogenesis and ﬁbril
packing, resulting in disrupted corneal stromal architecture and
function. The mechanism by which C-terminal truncation of
the decorin protein core alters SLRP expression is unknown.
Decorin, the most studied class I SLRP, has 12 leucine-
rich repeats (LRRs) in the central domain, ﬂanked by
Chen et alconserved cysteine-rich domains on either side.2,11e13 Sol-
uble decorin as a monomer in solution binds and modulates
various receptors and growth factors through different
domains.14 The central LRR5-6 contain key binding sites
for collagen I,15 the ectodomain of epidermal growth factor
receptor,16 and low-density lipoprotein receptorerelated
protein 1.17 LRR12 at the C-terminus can bind to connective
tissue growth factor.18 However, that the corneal stromal
phenotypes in both the human disease and the 952delTDcn
mouse model are distinct from that in the decorin-null
mouse model suggests that the effects of the C-terminal
truncation are not entirely explained by a loss-of-function
mutation.19 It may also function in a dominant negative
manner in which the truncated decorin transcribed from the
mutant allele competes with the normal decorin transcribed
from the normal allele. This could result in abnormal
functioning of decorin extracellularly during collagen ﬁbril
assembly and/or intracellularly during maturation of the full
proteoglycan.
Adjacent to the truncated 33 amino acids at the C-terminus
is LRR11, the longest repeat that extends laterally from the
main axis of the decorin protein core and is referred to as the
ear repeat, a characteristic feature of SLRPs. The ear repeat is
thought to participate in the protein folding of decorin and
may also contribute to ligand recognition.20 Herein we
demonstrate that absence of the C-terminal 33 amino acids
from the decorin protein core leads to a misfolded and
unstable/insoluble protein, indicating a pathogenic involve-
ment of the ear repeat. Moreover, our ﬁndings implicate for
the ﬁrst time decorin-evoked endoplasmic reticulum (ER)
stress that leads to the unfolded protein response. Thus, we
propose a novel cell-based mechanism for the observed
corneal opacity in which a truncated SLRP protein core is
retained intracellularly, its accumulation inducing ER stress
and resulting in abnormal SLRP synthesis and secretion,
which ultimately affects stromal assembly and corneal
transparency.
Materials and Methods
Animals
952delTDcn transgenic mice10 in Dcnþ/ and Dcn/
background21 and wild-type (WT) control mice were used
in the present study. All animal studies were performed in
compliance with animal protocols of the University of South
Florida Institutional Animal Care and Use Committee.
Transmission Electron Microscopy
Corneal samples from WT and 952delTDcn transgenic mice
were analyzed via transmission electron microscopy as
previously described.22 In brief, three corneas per group
were dissected and ﬁxed in 4% paraformaldehyde, 2.5%
glutaraldehyde, 0.1 mol/L sodium cacodylate (pH 7.4), and
8.0 mmol/L CaCl2 and were postﬁxed using 1% OsO4. The248corneas were dehydrated in graded ethanol followed by
propylene oxide. The tissue samples were inﬁltrated and
embedded in a mixture of EMbed 812, DMP-30 (both from
Leica Microsystems, Inc., Buffalo Grove, IL), nadicmethyl
anhydride, and dodecenyl succinic anhydride. Thin sections,
80 nm, were cut using an ultramicrotome (Leica Micro-
systems, Inc., Buffalo Grove, IL) and poststained with 2%
aqueous uranyl acetate and 1% phosphotungstic acid (pH
3.2). The sections were examined at 80 kV using a trans-
mission electron microscope (JEOL 1400; JEOL USA, Inc.,
Peabody, MA) equipped with a digital camera (Ultrascan
US1000 2K; Gatan, Inc., Warrendale, PA). For cell culture,
HEK293 cells were grown on coverslips in 12-well plates
and transfected with decorin or 952delT decorin. At 48
hours after transfection, cells were ﬁxed in 4% para-
formaldehyde, 2.5% glutaraldehyde, and 0.1 mol/L sodium
cacodylate (pH 7.4), with 8.0 mmol/L CaCl2, and processed
as described.23
Cell Culture and Reagents
A human embryonic kidney cell line (HEK293T) was
purchased from ATCC (Manassas, VA). The cell line was
maintained in Dulbecco’s modiﬁed Eagle’s medium con-
taining 10% fetal bovine serum, 1 antibiotic-antimycotic
solution, and 5 mg/mL gentamicin (Life Technologies Corp.,
Grand Island, NY) at 37C in a humidiﬁed atmosphere
containing 5% CO2/95% air. The cells were treated with
different reagents, including 2.5 mmol/L MG132, 20 mmol/L
NH4Cl, 10 mg/mL cycloheximide, and 2.5 mmol/L methyl-
b-cyclodextrin (all from Sigma, St. Louis, MO), to disrupt
homeostasis of cellular proteins in cell culture.
Plasmid Construction and Transfection
A full-length mouse decorin cDNA24 was used as the
template for generating the mutant mouse decorin cDNAs
(952 delT, 926 delG, and 932 delG), using a QuikChange
Multi Site-Directed Mutagenesis Kit (Stratagene Corp., La
Jolla, CA). WT decorin cDNA and mutant mouse decorin
cDNAs were individually cloned into the appropriate re-
striction sites of pcDNA3 vectors (Invitrogen Corp., Carls-
bad, CA). All plasmids were veriﬁed via gene sequencing.
HEK293T cells were seeded on mouse collagen Iecoated
coverslips in 6- or 12-well plates. Transfections of HEK293T
cells were performed according to the manufacturer’s
protocol using Lipofectamine 2000 dissolved in Opti-MEM I
(both from Invitrogen), which was replaced with serum-free
Dulbecco’s modiﬁed Eagle’s medium at 6 hours after trans-
fection. At 60 hours after transfection, the medium and cell
layers were harvested. To study the turnover of intracellular
decorin, the cells were trypsinized, rinsed with PBS, and
collected at different times after treatment with cyclohexi-
mide or cycloheximide plus MG132. A cotransfected
plasmid containing green ﬂuorescent protein was used as
transfection control.ajp.amjpathol.org - The American Journal of Pathology
Mutant Decorin Causes ER Stress in CSCDmRNA Analysis
Total RNA was isolated from transfected HEK293T cells
using Ribopure TM kits (Ambion, Inc., Austin, TX). Inde-
pendent cDNA preparations from different transfections
were obtained via reverse transcription of a series dilution of
RNA with random primers (High-Capacity cDNA Archive
Kit; Applied Biosystems, Inc., Foster City, CA). Real-time
RT-PCR was performed using the StepOnePlus system with
the SYBR Green PCR Master Mix (both from Applied
Biosystems). The primer sequences for decorin were as
follows: forward primer, 50-TGAGCTTCAACAGCATCA-
CC-30; reverse primer, 50-AAGTCATTTTGCCCAACTGC-30.
Actin was used as an endogenous control to standardize
the amount of sample RNA. The PCR parameters were
95C for 20 seconds followed by 40 cycles at 95C for 3
seconds and 60C for 30 seconds.
Antibodies, Immunoblots, and Phos-Tag Gels
Rabbit anti-decorin LF113; provided by Dr. Larry Fisher
(NIH, National Institute of Dental and Craniofacial Research,
Bethesda, MD)25 was used at 1:500 dilution, rabbit anti-BiP,
anti-PERK, and mouse anti-CHOP antibodies (Cell
Signaling Technology, Inc., Danvers, MA) were used at
1:200 dilution, and rabbit antiegreen ﬂuorescent protein
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used
at 1:500 dilution. Actin reactivity in each sample was
detected using an anti-actin antibody (Chemicon Interna-
tional, Temecula, CA) at 1:500 dilution. Proteins from cell
culture medium or cell layer lysates in radio-
immunoprecipitation assay buffer were separated using 4%
to 12%Bis-Tris gels (Invitrogen) and transferred to HyBond-
C membrane (Amersham Biosiences Corp., Piscataway, NJ)
for immunoblotting. Goat anti-rabbit or anti-mouse IgG-
peroxidase (Amersham Biosciences) was used as secondary
antibody at 1:3000 dilution with an ECL detection system
(Pierce Chemical Co., Rockford, IL). To remove O-linked
glycosaminoglycan (GAG) chains, serum-free medium from
transfected cell cultures was digested with chondroitinase
ABC (ChABC) (Seikagaku Corp., Tokyo, Japan) for 24
hours at 37C. The samples were denatured and digested with
peptide-N-glycosidase (PNGase F; ProZyme, Inc., San
Leandro, CA) using the manufacturer’s protocol to remove
the N-glycosylated oligosaccharides from decorin. Phos-tag
gels were performed as described for immunoblots, with
the exceptions that 7.5% SDS-PAGE containing 50 mmol/L
Phos-tag (Wako Chemical USA, Inc., Richmond, VA) and
50 mmol/L MnCl2 (Sigma) were used and the gels were
incubated in 1 mmol/L EDTA for 10 minutes before transfer.
Immunoﬂuorescence and Confocal Microscopy
Whole eyes, three to ﬁve per group, were embedded in
optimal cutting temperature compound (O.C.T.; Tissue-Tek,
Sakura Finetek USA Inc., Torrance, CA), frozen on dry ice,The American Journal of Pathology - ajp.amjpathol.organd stored at 80C. Frozen sections, 4 mm, were cut using
an HM505E cryostat (Themo Fisher Scientiﬁc, Inc., Hanover
Park, IL). The slides were blocked with 5% bovine serum
albumin in PBS, followed by addition of the primary anti-
bodies. The secondary antibody was Alexa Fluor 568- or
488-conjugated goat anti-rabbit IgG (Molecular Probes, Inc.,
Eugene, OR) used at 1:100 dilution. Vectashield mounting
solution with DAPI (Vector Laboratories, Inc., Burlingame,
CA) was used as a nuclear marker. Images were captured
using a Leica CTR 5500 microscope and Leica DFC 340 FX
camera. Identical conditions and set integration times were
used to facilitate comparisons between samples.
For immunocolocalization assays, transfected HEK293T
cells seeded on collagen Iecoated coverslips were ﬁxed in
4% paraformaldehyde and permeabilized with 0.3% Triton
X-100. Mouse monoclonal antieprotein disulﬁde isomerase
and antieGolgi 97 antibodies (Abcam, Cambridge, MA)
were used at 1:200 dilution for immunocolocalization assays.
Images were captured using a Leica TCS SP2 laser scanning
confocal microscope with a 60 1.42 numerical aperture oil
immersion lens. Samples were scanned sequentially using
405-, 488-, and 543-nm lasers, and emissions were collected
with appropriate spectral slit settings.
Results
Intracellular Localization and Increased Dilated
Membranous Organelles in Keratocytes Indicate
Retention of Mutant Decorin
Keratocytes are responsible for matrix synthesis and regu-
lation of corneal stromal structure. Localization of mutant
decorin was analyzed in the 952delTDcn mouse model of
human CSCD with expression in a decorin-null background.
The mutant decorin was intracellularly localized in kerato-
cytes. Immunolocalization of mutant decorin revealed
reactivity in the keratocyte cytoplasm, whereas reactivity in
the extracellular matrix was comparable to that observed in
the decorin-null genetic background (Figure 1, B and C). As
previously shown,10 WT decorin was localized almost
exclusively in the stromal extracellular matrix in the WT
corneas (Figure 1A). These data indicate that mutant decorin
might not be properly secreted and incorporated into the
stromal matrix.
Retention of mutant decorin was associated with enlarged
keratocytes harboring markedly dilated membranous cyto-
plasmic organelles (Figure 1E). These organelles are
consistent with Golgi and rough ER. In contrast, WT
controls demonstrated a well-organized stromal structure
with elongated ﬂattened keratocytes between lamellae
(Figure 1D). Keratocytes expressing mutant decorin were
signiﬁcantly larger than those in WT corneas, 1.34  0.46
mm versus 0.61  0.32 mm, respectively (P < 0.01).
Widespread presence of dilated membranous organelles
suggested retention of proteins in the synthetic/secretory
machinery of the 952delTDcn mouse model.249
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250Mutant Decorin Is Retained in Cytoplasm
To examine the secretion of mutant decorin, we used an
in vitro system using transfected HEK293T cells. HEK293T
cells were seeded on collagen Iecoated coverslips before
transfection and immunolocalization assays. The data
demonstrated that mostWT decorin was properly secreted and
associated with collagen I (Figure 2A). In contrast, mutant
decorin was localized almost exclusively in the cytoplasm of
the transfected HEK293T cells, with immunoreactivity within
the extracellular collagenous matrix below detection levels
(Figure 2B). All immunoﬂuorescence images were captured
using the same intensity, gain, and exposure time. Secretion of
mutant decorin was further determined by immunoblotting the
media and cell layer fractions from cultures of HEK293T cells
expressing mutant orWT decorin. Approximately 90% ofWT
decorin was secreted into the medium; however, we could not
detect any released mutant decorin, even after longer exposure
of the Western blots. All reactivity shown by the mutant
decorin was associated with the cell layer (Figure 2C). Thus,
the data clearly demonstrated that mutant decorin was not
secreted but was retained in the cytoplasm.
Retention of Mutant Decorin in ER Is Associated with
Dilated ER
As observed in our mouse model, retention of mutant
decorin was associated with enlarged keratocytes harboring
markedly dilated membranous cytoplasmic organelles. To
determine whether this morphologic change is a cellular
dysfunction or a secondary response to the disrupted
extracellular matrix, the ultrastructural morphologic change
also was studied using transfected HEK293T cells in vitro.
In agreement with our transgenic mouse model, compared
with WT transfected cells (Figure 3A), the 952delTDcn-
transfected 293 cells exhibited widespread dilated ER
(Figure 3B). Enlarged or dilated lysosomes and/or phag-
osomes were not observed.
Expression of Mutant Decorin Results in Lack of GAG
Chain Addition in the Golgi Apparatus
Decorin has a single O-linked GAG chain at the N-terminus,
whereas the central domain has three N-glycosylated oligo-
saccharides. One N-glycosylation site is near the truncatedFigure 1 Increaseddilatedmembranous organelles andhigher cytoplasmic
immunoreactivity for mutant decorin in 952delTDcn keratocytes. A: Decorin
localized almost exclusively in the stromal extracellularmatrix inWT corneas.B:
Virtually no immunoreactivity of decorin was detected in the corneal stroma
from decorin-deﬁcient mice. C: Immunolocalization of the mutant decorin
revealed higher reactivity of mutant decorin (white arrows) in the keratocyte
cytoplasm than in the extracellular matrix in a mutant mouse with decorin-null
background. Exposures in mice with decorin-null background were twofold
those in WTmice. Yellow arrows indicate the corneal stroma. D: Ultrastructural
analysis of thecorneal stroma showedﬂat keratocytes along the lamellar layer in
WTmice. E: In contrast, keratocytes were substantially enlarged, with increased
dilated membranous organelles (arrows), in 952delTDcn mice.
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Figure 2 Mutant decorin is retained in the cytoplasm. A: HEK293T cells
were seeded on collagen Iecoated coverslips before transfection and
immunolocalization assays. Most WT decorin was secreted and associated
with collagen I. B: In contrast, compared with WT decorin, mutant decorin
was not detectable outside the cell, and much higher immunoreactivity was
observed in the cytoplasm (arrows). C: Distribution in medium and cell
layer was different between WT and mutant decorin. Using cotransfected
green ﬂuorescent protein as a loading control, immunoblots showed that
almost 90% of WT decorin was secreted into the medium. In contrast to the
WT form, mutant decorin was undetectable in the medium, although levels
of cell layereassociated decorin were similar between the two forms of
decorin. These data clearly demonstrate that mutant decorin was retained
in the cytoplasm.
Figure 3 Retention of mutant decorin in the ER is associated with
dilated ER. HEK293T cells were transfected with either WT or mutant
decorin cDNA. In agreement with our transgenic mouse model, compared
with WT transfected cells (A, arrows), the 952delTDcn transfected 293 cells
have widely spread dilated membrane structures (B, thick arrows). Insets:
Magniﬁcation of areas indicated by arrow in A and thin arrow in B. Scale
bars: 2 mm (A and B).
Mutant Decorin Causes ER Stress in CSCDC-terminus. The GAG chain and the N-linked oligosaccha-
rides are important for protein folding and efﬁcient secretion.
To investigate whether the truncated C-terminus affected
decorin glycosylation, three mutant decorin constructs were
created and transfected into HEK293T cells. This yielded
cells expressing the mutations comparable to those reported
in families with human CSCD. A tag was not used, to
eliminate possible inﬂuences on trafﬁcking and the function
of the expressed proteins. To this end, we transfected
HEK293T cells with empty vector alone or with vectors
carrying either WT or mutant decorin cDNAs. Decorin
mRNA was undetectable in the cells transfected with vector
only. The mRNA levels of bothWT and mutant decorin were
similar, indicating comparable transfection efﬁciencies of the
two vectors (Figure 4A). Signiﬁcant decorin expression was
observed in HEK293T cells transfected with either WT or
952delT decorin (Figure 4B). Next, we sequentially digested
the samples with ChABC, which removes dermatan/
chondroitin sulfate, and PNGase F, which removes N-linked
oligosaccharides. As a consequence, expression of the
decorin protein core (Figure 4B) increased. In contrast, there
was no change in the 952delT decorin protein core after
ChABC treatment, indicating absence of glycanation of the
mutant form. N-deglycosylation by PNGase F led to a shift of
all of the O-deglycosylated bands on the immunoblots. The
distance between WT and truncated decorin bands after
O-deglycosylation remained constant on the immunoblots
after sequential deglycosylation with ChABC and PNGase FThe American Journal of Pathology - ajp.amjpathol.org(Figure 4B). Proteoglycans are modiﬁed with N-linked
oligosaccharides in the ER and with O-linked glycosami-
noglycan chains in the Golgi apparatus. Our data indi-
cated that the truncated C-terminus of decorin affected
O-glycosylation but not N-glycosylation, further sug-
gesting a speciﬁc deﬁciency of GAG chain attachment
and polymerization, presumed due to lack of transport
into the Golgi apparatus.Mutant Decorin Is Retained in ER with Abnormal
Transport/Secretion
Like all secreted glycoproteins and proteoglycans, WT
decorin protein core is synthesized in the ER; packaged in
the Golgi, where most of the posttranslational modiﬁca-
tions occur; transported in secretory vesicles; and ﬁnally
secreted into the extracellular matrix. It is also noteworthy
that secreted decorin can be endocytosed and transferred to
the lysosome for degradation.26,27 In HEK293T cells
transfected with WT decorin, immunocolocalization assays
showed low decorin immunoreactivity in the ER and
occasional scattered punctate reactivity that did not
colocalize with the ER marker, consistent with cytoplasmic
transport vesicles. The distribution of WT decorin in the251
Figure 5 Mutant decorin is retained in the ER with abnormal transport/
secretion. AeC: HEK293T cells were seeded on collagen Iecoated cover-
slips and transfected with either WT or 952delT decorin cDNA. Immuno-
colocalization demonstrated low immunoreactivity of decorin in the ER and
higher scattered punctate immunoreactivity that did not colocalize with
the ER marker (arrow in B) in cells transfected with WT decorin. DeF:
Substantially higher decorin immunoreactivity was colocalized with the ER
(arrows) in cells transfected with 952delT decorin. GeI: Immunocolocali-
zation indicated that punctate WT decorin colocalized with the Golgi
marker (arrows). JeL: In HEK293T cells transfected with mutant decorin,
although mutant decorin was highly expressed in the cytoplasm compared
with the controls, it did not colocalize with the Golgi marker. There was
limited reactivity against mutant decorin that colocalized with the Golgi
marker (yellow pixels indicated by the arrowhead in L). A part of the Golgi
is not colocalized with decorin (green pixels indicated by the arrow in L).
Scale bars: 25 mm (all panels).
Figure 4 Mutant decorin lacks O-linked GAG chains. A: HEK293T cells
were transfected with vector only, vector carrying WT decorin cDNA, or
vector carrying mutant decorin cDNA. Decorin mRNA was undetectable in
cells transfected with vector only. mRNA levels of decorin were
comparable between cells transfected with either WT or mutant decorin,
indicating similar transfection efﬁciency between the two groups. B: At
60 hours after transfection, proteins were collected from the cells. There
was virtually no endogenous decorin expression in HEK293 cells trans-
fected with vector only. Substantial decorin expression was observed in
cells transfected with either WT or 952delT decorin. The samples were
digested sequentially with ChABC and PNGase F. WT decorin bands
became sharper and thicker after removing the O-linked GAG chain with
ChABC; however, there was no change in the 952delT decorin band,
indicating lack of a GAG chain in the 952delT mutant decorin.
Furthermore, N-deglycosylation by PNGase F induced a shift in all of the
O-deglycosylated bands on the immunoblots. The distance between the
WT and truncated decorin bands after O-deglycosylation remained
constant on the immunoblots after sequential deglycosylation with
ChABC and PNGase F.
Chen et alcytoplasm was consistent with a constitutive secretory
pathway (Figure 5, AeC). Conversely, mutant decorin
showed a distinct localization pattern in transfected
HEK293T cells. Compared with WT decorin, mutant
decorin exhibited substantially greater colocalization with
the ER, indicating retention and abnormal intracellular
trafﬁcking of mutant decorin in the cytoplasm (Figure 5,
DeF).
The Golgi is critical for determining the destination of
proteins, in particular, its secretion. Our immunocolocali-
zation studies have indicated that the Golgi in WT decorin-
transfected cells was always associated with punctate
decorin (Figure 5, GeI). In HEK293T cells transfected with
mutant decorin, although much higher immunoreactivity of
mutant decorin was diffusely localized in the cytosol, only
a small fraction was associated with the Golgi (Figure 5,
JeL). These data suggest that mutant decorin had an
intrinsic deﬁciency in entering the Golgi apparatus,
corroborating the biochemical data showing deﬁciency in
O-glycosylation.252Mutant Decorin Is Degraded through the Ubiquitin-
Proteasome Pathway
The ﬁndings presented indicated differential localization/
transport of WT and mutant decorin within the ER/Golgi
boundaries. Thus, we investigated the intracellular turnover
of WT and mutant decorin by monitoring the behavior of
intracellular decorin over time after blocking newly
synthesized decorin with cycloheximide. We found that WT
decorin levels decreased over time, with an estimated t1/2 of
4.5 hours (Figure 6B), consistent with a combination of
intracellular lysosomal degradation and extracellular secre-
tion. Of note, although the mutant decorin was retained inajp.amjpathol.org - The American Journal of Pathology
Figure 7 Retention of mutant decorin in the ER leads to ER stress.
Immunoblots demonstrate substantially increased expression of CHOP, BiP,
and PERK in HEK293T cells transfected with mutant decorin compared with
those with WT decorin. Anti-actin bands were used as loading controls, and
antiegreen ﬂuorescent protein bands as transfection controls. Transfected
HEK293 cells were collected, lyzed, and loaded onto Phos-tag gels. Antie
phospho-PERK immunoblots show substantially increased reactivity in
cells transfected with 952delT decorin compared with those transfected
with WT decorin.
Figure 6 Mutant decorin is degraded through the ubiquitin-proteasome
pathway. HEK293T cells were transfected with either WT or mutant decorin
cDNA. At 36 hours after transfection, the cells were treated with cyclo-
heximide without (A and B) or with (C and D) MG132. Cells were trypsi-
nized, washed with PBS, and collected at 0, 6, 12, and 24 hours after
treatment. A and B: Immunoblots showed that intracellular decorin levels
decreased over time after treatment with cycloheximide. C and D: Combined
treatment with cycloheximide and MG132 substantially increased intracel-
lular decorin levels in cells transfected with 952delT decorin when
compared with those treated with WT decorin.
Mutant Decorin Causes ER Stress in CSCDthe ER, its signal also decreased over time, with a t1/2 of 7
hours, which suggests that alternative degradative pathways
were involved (Figure 6B).
The degradation pathway of mutant decorin was further
investigated through disrupting protein homeostasis using
various agents. MG132, a speciﬁc proteasome inhibitor,
substantially decreased mutant decorin degradation but did
not affect the levels of WT decorin (Figure 6D). Moreover,
neither methyl-b-cyclodextrin, an endocytosis inhibitor, nor
NH4Cl, a lysosomal inhibitor, interfered with mutant
decorin degradation (Supplemental Figure S1). Collectively,
our results demonstrate for the ﬁrst time that a truncated
C-terminal form of decorin is primarily degraded through
the ubiquitin-proteasome pathway.
Retention of Mutant Decorin in the ER Leads to ER
Stress
The ubiquitin-proteasome degradation pathway is often
a cellular response to various forms of stress. Because
mutant decorin is retained in the ER, we hypothesized that
the unfolded protein response or ER stress could be directly
implicated in the pathogenesis of CSCD. ER stress is
necessary in clearing improperly folded proteins through
enhancing the folding process or guiding unfolded proteins
to ubiquitin-proteasome degradation. The unfolded protein
response activates transcription factors through ATF6,
PERK, and IRE1 sensors, increasing synthesis of chaper-
ones and altering protein expression.28 The ER stress
markers Chop, BiP, and phospho-PERK in HEK293T cells
were substantially overexpressed when mutant rather thanThe American Journal of Pathology - ajp.amjpathol.orgWT decorin was expressed de novo (Figure 7). Next,
transfected HEK293T cell layers were collected, lysed, and
loaded onto Phos-tag gels. Phospho-PERK levels were
substantially elevated in mutant decorinetransfected cells
compared with controls, indicating increased phosphoryla-
tion (Figure 7). Thus, our data indicated that intracellularly
retained decorin protein core lacking the C-terminal ear
repeat caused ER stress.
Discussion
Decorin is a ubiquitous SLRP with extensive functions. Its
role in a speciﬁc biological context is complicated but also253
Chen et alﬁnely tuned by its trafﬁcking, secretion, and retention.
These processes determine its duration/concentration/
sequence of interactions with various molecules and, in turn,
its tissue-speciﬁc functions. CSCD is the only disease in
humans that is known to be associated with a mutated
decorin gene and clinically exhibits only a corneal stromal
phenotype.9 The present study demonstrates that truncation
of the decorin C-terminus results in a misfolded protein and
ER stress, providing a possible cell-based mechanism for
human CSCD. Moreover, it provides the ﬁrst evidence for
the importance of intracellular trafﬁcking in regulating
decorin function and the inﬂuence of ER stress on matrix
assembly in the corneal stroma.
The ER is an important part of the protein trafﬁcking
pathway and a major surveillance system that assists in
protein modiﬁcation, folding, and assembly. The ER
response to the burden of misfolded proteins involves
generation of stress signals activated by three ER stress
sensors: ATF6, PERK, and IRE1. The induced ER stress
signals regulate numerous genes to maintain protein
homeostasis.28 However, if the ER stress signals are too
strong to be mitigated, apoptosis may be induced. ER stress
is involved in many physiologic and pathologic condi-
tions.29 The present study indicates that retention of mutant
decorin in the ER increases ER stress substantially, which
could be a possible mechanism underlying human CSCD. In
normal conditions, ER stress is involved in normal clearing
of improperly folded proteins. In the heterozygous condi-
tion, keratocytes synthesize both WT and mutant decorin,
which substantially increases ER stress. Responding to the
increased ER stress signals, keratocytes may reprogram
themselves and become dedifferentiated; therefore, the cells
may change their expression of many extracellular matrix
components such as SLRPs. Keratocytes could survive ER
stress in development but lose their tissue-speciﬁc functions.
In the homozygous condition, increased mutant decorin in
the ER may result in strong ER stress signals that induce
apoptosis, causing cell death. In development, this may
result in an embryonic lethal phenotype. Compared with
other connective tissues, keratocytes synthesize large
amounts of decorin and also secrete other SLRPs into the
corneal stroma.30 Therefore, the corneal stroma, compared
with other connective tissues, is vulnerable to decorin
mutation. The present study provides a logical explanation
for the cornea-speciﬁc phenotype resulting from decorin
mutation in human CSCD.
The corneal stroma is uniquely organized, with regularly
packed, homogeneous, small-diameter ﬁbrils arranged as
orthogonal lamellae required for transparency.31 Coopera-
tive interactions involving decorin and other SLRPs are
important in tightly regulating the ﬁbrillogenesis required
for assembly of the corneal stroma and, therefore,
function.19,32e34 However, the sites where these regulatory
interactions occur, ie, intracellular, extracellular or both, and
the roles of cooperative interactions involving various
SLRPs, have not been deﬁned. In SLRP-deﬁcient mouse254models, the frequently observed phenotype is heterogeneous
larger collagen ﬁbrils with cauliﬂower proﬁles in the corneal
stroma.1 The phenotype suggests extracellular regulation of
the lateral growth of collagen ﬁbrils through interactions
with dynamic SLRPs inﬂuenced by local concentration and
diffusing. Our 952delTDcn mouse model demonstrated
a disrupted collagen ﬁbril assembly that was distinct from
those in SLRP-deﬁcient mouse models.10
Procollagens are folded and assembled in the ER. The
process is regulated by the ER enzyme prolyl 4-hydroxylase
and the molecular chaperone HSP47.35,36 Differential pro-
teomic analysis conﬁrmed the association of highly
expressed decorin with endoplasmin, an ER chaperone, in
breast cancer.37 Whether retention of mutant decorin in the
ER disturbs procollagen folding and assembly requires
further investigation. Mutant decorin could disrupt the
interactions between these chaperones and procollagen
directly or indirectly through ER stress signals. Alterna-
tively, retained mutant decorin in the ER may interact with
or increase the retention/degradation of other SLRPs. We
have previously demonstrated that expression of mutant
truncated decorin led to decreased synthesis of KS-lumican
and KS-keratocan in keratocytes, which could partially
explain the altered collagen matrix observed in patients with
CSCD.10,22,38,39
The N-terminus of decorin harbors the signal peptide
that is important for decorin secretion. However, the
possibility that the truncated C-terminus could affect the
N-terminus is remote. The frameshift mutations neither
introduce nor expose the ER retention sequence KDEL
(Lys-Asp-Glu-Leu) in the C-terminus after truncation. Of
note, N-terminal truncations of decorin lacking the 14-
amino acid propeptide generate decorin isoforms with
shorter GAG chains,40 indicating that the protein core with
N-terminal truncation can undergo glycanation in the
Golgi apparatus. N-glycosylation is important for secre-
tion41; however, the present study did not show its absence
in truncated decorin. The reported three frameshift muta-
tions all affect the ear repeat, which is proposed to maintain
the conformation of the protein core and inﬂuence ligand
binding. The C-terminal cysteine-rich domain is critical for
stability of the ear repeat, and a milder form of CSCD
involves a nucleotide substitution (c.1036T>G) in this
region, resulting in a substitution of 346 cysteine with
glycine.42 The observed milder phenotype would be
consistent with less severe disruption of the regional struc-
ture inﬂuencing protein core structure less, resulting in less
ER stress. The mechanism by which mutant decorin is
retained in the ER with altered ability to enter the Golgi
requires further investigation to develop strategies to relieve
ER stress in human CSCD.
In conclusion, C-terminal truncation of decorin induced
misfolded, unstable, or insoluble decorin that was retained
in the ER and could not progress to the next physiologic
compartment such as the cis-Golgi, thereby leading to
a block in its secretion. The intracellularly retained andajp.amjpathol.org - The American Journal of Pathology
Mutant Decorin Causes ER Stress in CSCDmisfolded decorin induced ER stress. These in vitro ﬁndings
correlate well with our in vivo observations of enlarged
keratocytes, increased dilated membranous organelles, and
intracellular immunoreactivity of mutant decorin in the
corneas of transgenic mice expressing the same mutant
decorin. Therefore, the ER stress induced by truncated
decorin is a novel cell-based mechanism for human CSCD.
Future work to understand how the distribution of decorin is
regulated in a tissue-speciﬁc context, such as corneal
stromal matrix assembly, is of great pathophysiologic
importance.
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